Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise

Journal of the American College of Cardiology

Volumn 33, Issue 6, 1999, Pages 1567-1572

  Warner Jr , James G ^a   Metzger, D Christopher ^a   Kitzman, Dalane W ^a   Wesley, Deborah J ^a   Little, William C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; LOSARTAN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOUBLE BLIND PROCEDURE; EXERCISE TOLERANCE; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; DIASTOLE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; QUALITY OF LIFE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033133517     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00048-0     Document Type: Article

References (25)

1. Little WC, Downes TR. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 1990;32:273-90.
2. Little WC, Warner JG Jr, Rankin KM, et al. Evaluation of left ventricular diastolic function from the pattern of left ventricular filling. Clin Cardiol 1998;21:5-9.
3. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol 1997;30:8-18.
4. Cheng CP, Igarashi Y, Little WC. Mechanism of augmented rate of left ventricular filling during exercise. Circ Res 1992;70:9-19.
5. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension 1996;27:144-7.
6. Stratton JR, Levy WC, Cerqueira MD, et al. Cardiovascular responses to exercise: effects of aging and exercise training in healthy men. Circulation 1994;89:1648-55.
7. Fleg JL, O'Connor F, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995;78:890-900.
8. Fagard R, Staessen J, Thijs L, Amery A. Prognostic significance of exercise versus resting blood pressure in hypertensive men. Hypertension 1991;17:574-8.
9. Aldigier JC, Huang H, Dalmay F, et al. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993;21:289-95.
10. Cheng CP, Suzuki M, Ohte N, et al. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure. Circ Res 1996;78:880-92.
11. Haber HL, Powers ER, Gimple LW, et al. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 1994;89: 2616-25.
12. Friedrich SP, Lorell BH, Rousseau MF, et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994;90:2761-71.
13. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1995;1:201-6.
14. Bruce RA. Exercise testing methods and interpretations. Adv Cardiol 1978;24:6-15.
15. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
16. Oh JK, Appleton CP, Hatle LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246-70.
17. Glantz SA. Primer of Bio-Statistics. 2nd ed. New York: McGraw-Hill, 1987.
18. Kitzman DW, Sheikh KH, Beere PA, et al. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility, and loading conditions. J Am Coll Cardiol 1991;18:1243-50.
19. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994;89:2241-50.
20. Little WC, Braunwald E. Assessment of cardiac function. In: Braunwald E, editor. Heart Disease. 5th ed. Philadelphia: W.B. Saunders, 1997:421-44.
21. Setaro JF, Zaret BL, Schulman DS, Black HR. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990;66:981-6.
22. Bonow RO, Dilsizian V, Rosing DR, et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985;72:853-64.
23. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985;312:277-83.
24. Lo MW, Goldberg MR, McCrea JB, et al. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther 1995;58:641-9.
25. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.